SCHEMBL19960144

SCHEMBL19960144

O=P(c1ccc2ccccc2c1)(c1ccc2ccc3ccccc3c2c1)c1cccc2c1ccc1c3ccccc3n3c4ccccc4nc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.35
KMT2A Q03164 5/20 0.35
MAPT P10636 5/20 0.35
CYP1A2 P05177 3/20 0.35
MEN1 O00255 3/20 0.35
CAMKK1 Q8N5S9 2/20 0.35
CAMKK2 Q96RR4 2/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
POLB P06746 3/20 0.34
NPC1 O15118 1/20 0.34
CYP3A4 P08684 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959884 0.94 BCL2 (0.34) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19960131 0.93 BCL2 (0.35) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19959842 0.91 BCL2 (0.36) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19959933 0.88 KDM4E (0.36) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19959798 0.88 KDM4E (0.36) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19960137 0.88 USP2 (0.33) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19960181 0.87 BCL2 (0.36) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19960166 0.85 BCL2 (0.34) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19959894 0.85 KDM4E (0.39) BCL2KMT2AMAPTCYP1A2MEN1
SCHEMBL19959886 0.85 KDM4E (0.39) BCL2KMT2AMAPTCYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 BCL2 2578/4885KMT2A 443/4885MAPT 1310/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 BCL2 2578/4885KMT2A 443/4885MAPT 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.